Showing results (691-700 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|October 25, 2026
Protective effects of testosterone replacement therapy on brain tumor outcomes: The Mayo Clinic experienceManuel M Bettencourt, Shreya Gandhi, Archis Bhandarkar, et al.
Neuro-Oncology Advances|November 6, 2026
Performance of intraoperative artificial intelligence-assisted label-free stimulated Raman histology in recurrent brain tumorsGina Fürtjes, Abdulkader Al Shughri, Thomas Stehle, et al.
Neuro-Oncology Advances|September 21, 2022
Transcranial magnetic stimulation (TMS) seeded tractography provides superior prediction of eloquence compared to anatomic seeded tractographyMatthew Muir, Sarah Prinsloo, Hayley Michener, et al.
Neuro-Oncology Advances|September 21, 2022
Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysisRituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, et al.
Neuro-Oncology Advances|October 27, 2022
Artificial neural networks predict the need for permanent cerebrospinal fluid diversion following posterior fossa tumor resectionDavid P Bray, Hassan Saad, James Miller Douglas, et al.
Neuro-Oncology Advances|February 13, 2025
Radiotherapy and radiosurgery for intracranial lesions in Africa: Insights from 3 country case studies: A systematic reviewIshav Shukla, Jason Wang, Mina Guirguis, et al.
Neuro-Oncology Advances|January 29, 2025
Therapeutic manipulation and bypass of the blood-brain barrier: powerful tools in glioma treatmentAlexandra M Giantini-Larsen, Abhinav Pandey, Andrew L A Garton, et al.
Neuro-Oncology Advances|January 10, 2025
Abdominal myosteatosis measured with computed tomography predicts poor outcomes in patients with glioblastomaFarzaneh Rahmani, Garrett Camps, Olesya Mironchuk, et al.
Neuro-Oncology Advances|December 30, 2024
Stalking the stalk: Isolated pituitary stalk thickening and predictive factors for proliferative diseaseJulie Bennett, Liana Nobre, Eric Bouffet, et al.
Neuro-Oncology Advances|December 2, 2024
Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patientsLouis Larrouquere, Christelle Dufour, Cécile Faure-Conter, et al.
Pageof 138